CGRP Modulating Therapies: An Update.
Curr Neurol Neurosci Rep
; 24(9): 453-459, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-39017828
ABSTRACT
INTRODUCTION:
Calcitonin-gene related peptide (CGRP) is a vasoactive neuropeptide involved in the pathophysiology ofmigraine. CGRP has been targeted for both preventive and acute treatment of migraine.OBJECTIVE:
Provide a summary of the most clinically relevant literature surrounding CGRP modulating therapies.METHODS:
This update on CGRP modulating therapies includes articles selected as most clinically relevant by theauthors.CONCLUSION:
CGRP modulating therapies are an exciting new addition to migraine treatment given their safety andtolerability. Additionally, compared to traditional migraine preventive medication these treatments are migrainespecific.Further real-world and clinical data is ongoing to better understand these treatments that continue to gainfavor in the management of migraine.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Calcitonin Gene-Related Peptide
/
Migraine Disorders
Limits:
Humans
Language:
En
Journal:
Curr Neurol Neurosci Rep
Journal subject:
NEUROLOGIA
Year:
2024
Document type:
Article
Affiliation country:
United States
Country of publication:
United States